BR9607427A - Inhibition of angiogenes using interleukin 12 - Google Patents
Inhibition of angiogenes using interleukin 12Info
- Publication number
- BR9607427A BR9607427A BR9607427A BR9607427A BR9607427A BR 9607427 A BR9607427 A BR 9607427A BR 9607427 A BR9607427 A BR 9607427A BR 9607427 A BR9607427 A BR 9607427A BR 9607427 A BR9607427 A BR 9607427A
- Authority
- BR
- Brazil
- Prior art keywords
- angiogenes
- interleukin
- inhibition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38938295A | 1995-02-16 | 1995-02-16 | |
PCT/EP1996/000507 WO1996025171A1 (en) | 1995-02-16 | 1996-02-07 | Inhibition of angiogenesis using interleukin-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9607427A true BR9607427A (en) | 1998-06-23 |
Family
ID=23538033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9607427A BR9607427A (en) | 1995-02-16 | 1996-02-07 | Inhibition of angiogenes using interleukin 12 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0809511A1 (en) |
JP (1) | JPH11500119A (en) |
AU (1) | AU4788396A (en) |
BR (1) | BR9607427A (en) |
CA (1) | CA2212370A1 (en) |
FI (1) | FI973356A (en) |
TR (1) | TR199700801T1 (en) |
WO (1) | WO1996025171A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998022129A1 (en) * | 1996-11-22 | 1998-05-28 | Toray Industries, Inc. | Therapeutic agent for ophthalmic diseases |
US6670337B1 (en) | 1998-01-29 | 2003-12-30 | Yeda Reaearch And Development Co., Ltd. | Facilitation of wound healing with CM101/GBS toxin |
US5981508A (en) | 1997-01-29 | 1999-11-09 | Vanderbilt University | Facilitation of repair of neural injury with CM101/GBS toxin |
US5858991A (en) * | 1997-01-29 | 1999-01-12 | Vanderbilt University | Facilitation of wound healing with CM101/GBS toxin |
US6028060A (en) * | 1997-01-29 | 2000-02-22 | Vanderbilt University | Treatment of chronic inflammatory diseases with CM101/GBS toxin |
US6660258B1 (en) | 1997-05-09 | 2003-12-09 | Pharma Pacific Pty Ltd | Oromucosal cytokine compositions and uses thereof |
WO1998053835A1 (en) * | 1997-05-27 | 1998-12-03 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
CA2308438A1 (en) * | 1997-11-03 | 1999-05-14 | The Wistar Institute Of Anatomy And Biology | Method and compositions for inhibiting angiogenesis and treating cancer |
CA2442210C (en) | 2001-03-29 | 2009-09-08 | Schering Corporation | Aryl oxime-piperazines useful as ccr5 antagonists |
WO2004060373A1 (en) * | 2002-12-27 | 2004-07-22 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for wet age-related macular degeneration |
JP4485520B2 (en) | 2003-03-24 | 2010-06-23 | エフ.ホフマン−ラ ロシュ アーゲー | Benzyl-pyridazinones as reverse transcriptase inhibitors |
WO2007045573A1 (en) | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
AU2007286345B2 (en) | 2006-08-16 | 2012-03-08 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
AU2007332654B2 (en) | 2006-12-13 | 2013-06-20 | F. Hoffmann-La Roche Ag | 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
US20240181010A1 (en) * | 2016-07-18 | 2024-06-06 | Neumedicines Inc. | Uses of il-12 as a replacement immunotherapeutic |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06506702A (en) * | 1992-01-16 | 1994-07-28 | レプリゲン コーポレーション | Novel methods and compositions for the treatment of angiogenic diseases |
JPH06157344A (en) * | 1992-02-07 | 1994-06-03 | Childrens Medical Center Corp:The | Preparation for blocking new formation of blood vessel and method of blocking new formation of blood vessel |
-
1996
- 1996-02-07 JP JP8524631A patent/JPH11500119A/en active Pending
- 1996-02-07 WO PCT/EP1996/000507 patent/WO1996025171A1/en not_active Application Discontinuation
- 1996-02-07 AU AU47883/96A patent/AU4788396A/en not_active Abandoned
- 1996-02-07 TR TR97/00801T patent/TR199700801T1/en unknown
- 1996-02-07 BR BR9607427A patent/BR9607427A/en not_active Application Discontinuation
- 1996-02-07 CA CA002212370A patent/CA2212370A1/en not_active Abandoned
- 1996-02-07 EP EP96904008A patent/EP0809511A1/en not_active Withdrawn
-
1997
- 1997-08-15 FI FI973356A patent/FI973356A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2212370A1 (en) | 1996-08-22 |
FI973356A0 (en) | 1997-08-15 |
WO1996025171A1 (en) | 1996-08-22 |
AU4788396A (en) | 1996-09-04 |
EP0809511A1 (en) | 1997-12-03 |
TR199700801T1 (en) | 1998-03-21 |
JPH11500119A (en) | 1999-01-06 |
FI973356A (en) | 1997-08-15 |
MX9706188A (en) | 1997-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9609772A (en) | Reduction of bio-fouling | |
DE59605821D1 (en) | 1/4 SCALLABSORBER | |
BR9609797A (en) | Inhibition of gene expression | |
BR9611130A (en) | Derivatives of 3-aryl-5-halogen-pyrone | |
BR9609726A (en) | Inhibition of gene expression | |
BR9611475A (en) | Acylated 5-aminoisothiaz | |
BR9607427A (en) | Inhibition of angiogenes using interleukin 12 | |
IT1276799B1 (en) | FORMULATIONS OF F-SILICONE | |
FR2731885B1 (en) | INSTALLATION OF REMOVABLE SHELVES | |
NO961404D0 (en) | 4 indolylpiperazinyl derivatives | |
GB9621852D0 (en) | Inhibition of scale | |
NO960353D0 (en) | 4 aminobenzoylguanidinderivater | |
BR9607046A (en) | Derivatives of 3-pyrrolidiliden-2-one-cephalosporins | |
NO960392L (en) | 4 merkaptobenzoylguanidinderivater | |
FI953319A0 (en) | Manufacture of dimethylnaphthalene | |
FR2735986B3 (en) | HALTERA EXTENSION | |
PT761766E (en) | ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE | |
UA1112S (en) | MICRO-EOM OF WIDE PURPOSE | |
KR970011853U (en) | New form of maryas | |
KR970027978U (en) | Structure of slide hammer | |
ITMI951551A0 (en) | OROSOLUBLE COMPOSITIONS OF N-ACETYLCISTEINE | |
ITTV950114A0 (en) | STRUCTURE OF TABLE-STOOL | |
KR960031416U (en) | Spindle of Thrower | |
KR970041939U (en) | Dust-tightening structure of parts | |
IS4339A (en) | Photocompetition inhibition of 3-substituted-2-oxindoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |